Zobrazeno 1 - 10
of 1 908
pro vyhledávání: '"il-1ra"'
Publikováno v:
Clinical Immunology Communications, Vol 6, Iss , Pp 9-14 (2024)
Deficiency of Interleukin-1 receptor antagonist (DIRA) is a rare autosomal recessive autoinflammatory disease first reported in 2009. To date, 33 patients have been previously characterized and reported in literature. To the best of our knowledge, th
Externí odkaz:
https://doaj.org/article/127c1d1a0db9422cb7cbe23a4bf0bd26
Publikováno v:
BMC Pregnancy and Childbirth, Vol 24, Iss 1, Pp 1-7 (2024)
Abstract Objective This study aims to assess the prognostic and diagnostic value of inflammatory indexes related to gestational diabetes mellitus (GDM) from the second trimester to the third trimester of pregnancy. Materials and methods In this study
Externí odkaz:
https://doaj.org/article/0a2a6b2680114a5a8e5498e001563a86
Autor:
Fatemeh Shafiee, Ali Yazdani
Publikováno v:
Research in Pharmaceutical Sciences, Vol 19, Iss 3, Pp 356-365 (2024)
Background and purpose: Anakinra must be injected daily due to its short half-life and this leads to lower patient compliance. Therefore, the aim of this study was to produce an interleukin-1 receptor antagonist (IL-1Ra) with albumin binding domain (
Externí odkaz:
https://doaj.org/article/f78eba8011f5450bb6e5f5477d9b79ad
Autor:
Lifan Zhang, Zhengrong Yang, Fengying Wu, Qiping Ge, Yueqiu Zhang, Dongyu Li, Mengqiu Gao, Xiaoqing Liu
Publikováno v:
BMC Infectious Diseases, Vol 24, Iss 1, Pp 1-12 (2024)
Abstract Background More efficient and convenient diagnostic method is a desperate need to reduce the burden of tuberculosis (TB). This study explores the multiple cytokines secretion based on QuantiFERON-TB Gold Plus (QFT-Plus), and screens for opti
Externí odkaz:
https://doaj.org/article/6f5d579730d947ea8d0ea7a8f38873c0
Autor:
Dongze Liu, Zheng Qin, Bocun Yi, Hongbo Xie, Yunan Liang, Liang Zhu, Kuo Yang, Hongtuan Zhang
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
ObjectivesInflammatory cytokines (ICs) play an important role in erectile dysfunction (ED). Previous studies have demonstrated that most ED patients have high levels of tumor necrosis factor-α (TNF-α), interleukin-6 (IL-6) and interleukin-8 (IL-8).
Externí odkaz:
https://doaj.org/article/14e2fef3a1b94a7ead04be8826b38ee6
Autor:
Shyng-Shiou F. Yuan, Yun-Ming Wang, Leong-Perng Chan, Amos C. Hung, Hieu D. H. Nguyen, Yuk-Kwan Chen, Stephen Chu‐Sung Hu, Steven Lo, Yen-Yun Wang
Publikováno v:
Journal of Translational Medicine, Vol 21, Iss 1, Pp 1-19 (2023)
Abstract Background Interleukin-1 receptor antagonist (IL-1RA), a member of the IL-1 family, has diverse roles in cancer development. However, the role of IL-1RA in oral squamous cell carcinoma (OSCC), in particular the underlying mechanisms, remains
Externí odkaz:
https://doaj.org/article/58caeefba9954be9870ef0a9b278add6
Publikováno v:
Bioactive Materials, Vol 25, Iss , Pp 307-318 (2023)
Bone morphogenetic protein (BMP-2) has been approved by the FDA to promote bone regeneration, but uncertain osteogenic effect and dose-dependent side effects may occur. Osteoimmunomodulation plays an important role in growth factor-based osteogenesis
Externí odkaz:
https://doaj.org/article/dfe22759fc7e402eb4c5b6bdb44fafb0
Autor:
Lena Mahmoudi Azar, Elif Karaman, Burcu Beyaz, Işılay Göktan, Alp Ertunga Eyüpoğlu, Seda Kizilel, Batu Erman, Ahmet Gül, Serdar Uysal
Publikováno v:
BMC Biotechnology, Vol 23, Iss 1, Pp 1-15 (2023)
Abstract Background The interleukin-1 receptor antagonist (IL-1Ra) is a crucial molecule that counteracts the effects of interleukin-1 (IL-1) by binding to its receptor. A high concentration of IL-1Ra is required for complete inhibition of IL-1 activ
Externí odkaz:
https://doaj.org/article/0a4e30a6c21b43f6a76ed74cbb1d989a
Publikováno v:
Molecules, Vol 29, Iss 12, p 2787 (2024)
Nutraceutical immune support offers potential for designing blends with complementary mechanisms of action for robust support of innate immune alertness. We documented enhanced immune activation when bovine colostrum peptides (BC-Pep) were added to a
Externí odkaz:
https://doaj.org/article/524bc83edb634630942cedf41b22a0f2
Publikováno v:
Medical Journal of Babylon, Vol 20, Iss 4, Pp 875-881 (2023)
Background: Human herpesvirus 8 (HHV-8) stimulates lymphoproliferation, by activating the signaling pathway of the interleukin-6 receptor, along with several other regulatory mechanisms. The presence of specific genetic variations governing immune re
Externí odkaz:
https://doaj.org/article/7e6886d3c7fe4884afdfc6f830a838a1